These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 27510740)

  • 1. Physician Recommendations Trump Patient Preferences in Prostate Cancer Treatment Decisions.
    Scherr KA; Fagerlin A; Hofer T; Scherer LD; Holmes-Rovner M; Williamson LD; Kahn VC; Montgomery JS; Greene KL; Zhang B; Ubel PA
    Med Decis Making; 2017 Jan; 37(1):56-69. PubMed ID: 27510740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Informed Decision Making: Assessment of the Quality of Physician Communication about Prostate Cancer Diagnosis and Treatment.
    Holmes-Rovner M; Montgomery JS; Rovner DR; Scherer LD; Whitfield J; Kahn VC; Merkle EC; Ubel PA; Fagerlin A
    Med Decis Making; 2015 Nov; 35(8):999-1009. PubMed ID: 26304063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patients' and urologists' preferences for prostate cancer treatment: a discrete choice experiment.
    de Bekker-Grob EW; Bliemer MC; Donkers B; Essink-Bot ML; Korfage IJ; Roobol MJ; Bangma CH; Steyerberg EW
    Br J Cancer; 2013 Aug; 109(3):633-40. PubMed ID: 23860533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selecting men diagnosed with prostate cancer for active surveillance using a risk calculator: a prospective impact study.
    van Vugt HA; Roobol MJ; van der Poel HG; van Muilekom EH; Busstra M; Kil P; Oomens EH; Leliveld A; Bangma CH; Korfage I; Steyerberg EW
    BJU Int; 2012 Jul; 110(2):180-7. PubMed ID: 22112199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors influencing treatment decision making and information preferences of prostate cancer patients on active surveillance.
    Davison BJ; Breckon E
    Patient Educ Couns; 2012 Jun; 87(3):369-74. PubMed ID: 22177658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient Factors That Influence How Physicians Discuss Active Surveillance With Low-Risk Prostate Cancer Patients: A Qualitative Study.
    Brooks JV; Ellis SD; Morrow E; Kimminau KS; Thrasher JB
    Am J Mens Health; 2018 Sep; 12(5):1719-1727. PubMed ID: 29973123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perceptions of Urologists About the Conversational Elements Leading to Treatment Decision-Making Among Newly Diagnosed Prostate Cancer Patients.
    Adsul P; Wray R; Boyd D; Weaver N; Siddiqui S
    J Cancer Educ; 2017 Sep; 32(3):580-588. PubMed ID: 27029194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Physician Recommendation Coding System (PhyReCS): A Reliable and Valid Method to Quantify the Strength of Physician Recommendations During Clinical Encounters.
    Scherr KA; Fagerlin A; Williamson LD; Davis JK; Fridman I; Atyeo N; Ubel PA
    Med Decis Making; 2017 Jan; 37(1):46-55. PubMed ID: 27343015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient preferences and urologist recommendations among local-stage prostate cancer patients who present for initial consultation and second opinions.
    Ramsey SD; Zeliadt SB; Fedorenko CR; Blough DK; Moinpour CM; Hall IJ; Smith JL; Ekwueme DU; Fairweather ME; Thompson IM; Keane TE; Penson DF
    World J Urol; 2011 Feb; 29(1):3-9. PubMed ID: 20959991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do Urology Male Patients Prefer Same-Gender Urologist?
    Amir H; Beri A; Yechiely R; Amir Levy Y; Shimonov M; Groutz A
    Am J Mens Health; 2018 Sep; 12(5):1379-1383. PubMed ID: 27222116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patients' preferences for communicating a prostate cancer diagnosis and participating in medical decision-making.
    Davison BJ; Parker PA; Goldenberg SL
    BJU Int; 2004 Jan; 93(1):47-51. PubMed ID: 14678366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple physician recommendations for prostate cancer treatment: a Pandora's box for patients?
    Underwood W; Orom H; Poch M; West BT; Lantz PM; Chang SS; Fowke JH
    Can J Urol; 2010 Oct; 17(5):5346-54. PubMed ID: 20974025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality of physician-patient relationships is associated with the influence of physician treatment recommendations among patients with prostate cancer who chose active surveillance.
    Orom H; Homish DL; Homish GG; Underwood W
    Urol Oncol; 2014 May; 32(4):396-402. PubMed ID: 24332649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Communication preferences of patients with prostate cancer : Preferences regarding the communication of bad news of patients with prostate cancer in Germany-results of an anonymous patient survey].
    Merseburger AS; Kramer MW; Scheithe K; Colling C
    Urologe A; 2016 Oct; 55(10):1339-1346. PubMed ID: 27306355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How do patients choose between active surveillance, radical prostatectomy, and radiotherapy? The effect of a preference-sensitive decision aid on treatment decision making for localized prostate cancer.
    Lamers RE; Cuypers M; de Vries M; van de Poll-Franse LV; Ruud Bosch JL; Kil PJ
    Urol Oncol; 2017 Feb; 35(2):37.e9-37.e17. PubMed ID: 28341494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Shared Decision-Making in Patients With Prostate Cancer in Japan: Patient Preferences Versus Physician Perceptions.
    Schaede U; Mahlich J; Nakayama M; Kobayashi H; Takahashi Y; Saito K; Uemura H; Tokumitsu M; Yoshizawa K
    J Glob Oncol; 2018 Sep; 4():1-9. PubMed ID: 30241183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urologists' attitudes regarding information sharing with prostate cancer patients--is there a common ground for collaboration with family physicians?
    Cohen Castel O; Alperin M; Ungar L; Kravtsov I; Amiel GE; Karkabi K
    J Cancer Educ; 2011 Jun; 26(2):315-21. PubMed ID: 20972846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment Preferences for Active Surveillance versus Active Treatment among Men with Low-Risk Prostate Cancer.
    Taylor KL; Hoffman RM; Davis KM; Luta G; Leimpeter A; Lobo T; Kelly SP; Shan J; Aaronson D; Tomko CA; Starosta AJ; Hagerman CJ; Van Den Eeden SK
    Cancer Epidemiol Biomarkers Prev; 2016 Aug; 25(8):1240-50. PubMed ID: 27257092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Why do some patients prefer to leave decisions up to the doctor: lack of self-efficacy or a matter of trust?
    Chawla N; Arora NK
    J Cancer Surviv; 2013 Dec; 7(4):592-601. PubMed ID: 23892559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of a protein-based assay that predicts prostate cancer aggressiveness on urologists' recommendations for active treatment or active surveillance: a randomized clinical utility trial.
    Peabody JW; DeMaria LM; Tamondong-Lachica D; Florentino J; Czarina Acelajado M; Ouenes O; Richie JP; Burgon T
    BMC Urol; 2017 Jul; 17(1):51. PubMed ID: 28673277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.